Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin
Source abstract
Abstract
Unlabelled To solve the contradiction between long circulation time and effective intracellular drug release, redox and pH-responsive drug delivery system was developed by incorporated redox-sensitive disulfide linkage between poly(amidoamine) dendrimers (PAMAM) and poly(ethylene glycol) (PEG). Doxorubicin (DOX) was loaded into the hydrophobic core of the conjugates to prepare PAMAM-SS-PEG/DOX complexes (PSSP/DOX). In vitro release studies suggested that DOX release from PSSP/DOX complexes followed an redox and acid-triggered manner and increased with increasing PEGylation degree. In vitro cytotoxicity of PSSP/DOX complexes against B16 tumor cells increased with, while cellular uptake decreased with increasing PEGylation degree. Further, intracellular DOX release observation and measurement indicate that the intracellular DOX release played a critical role for the cytotoxicity of DOX-loaded PSSP conjugates. In addition, cellular entry mechanism of the PSSP/DOX study demonstrated that both clathrin- and caveolae-mediated endocytosis were the primary pathways for cellular entry of PSSP/DOX. Finally, in vivo study of PSSP/DOX complexes in B16 tumor-bearing mice indicate that PSSP/DOX could significantly improve antitumor efficiency and present a good safety. The redox and pH-responsive drug delivery system has been demonstrated to be a promising candidate for solid tumor therapy. Statement of significance In previous research, pH-sensitive diblock polymer of poly(ethylene glycol)-poly(2,4,6-trimethoxybenzylidene-pentaerythritol carbonate) (PEG-PTMBPEC) was synthesized to facilitate the intracellular anticancer drug release. However, the nanoparticles based on PEG-PTMBPEC get into the tumor cells just relying on the EPR-mediated passive targeting resulting in the low drug accumulation. Therefore, cRGD peptide modified PEG-PTMBPEC polymeric micelles were developed for specific targeted delivery of doxorubicin (DOX) to neovascular cells and tumor cells simultaneously. The precise intracellular target site and effective drug concentration will contribute to enhancing the antitumor toxicity and reducing the systematic toxicity of DOX. The cRGD modified pH-sensitive micellar system is a promising vehicle for intracellular drug delivery to αvβ3 integrin receptor overexpressed tumor cells and neovascular cells.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery10.1016/j.jconrel.2011.01.030 ↗
2. Biodegradable polymeric nanoparticles as drug delivery devices10.1016/S0168-3659(00)00339-4 ↗
3. Dendrimers as versatile platform in drug delivery applications10.1016/j.ejpb.2008.09.023 ↗
4. A new class of polymers: starburst-dendritic macromolecules
5. Dendrimers and dendritic polymers in drug delivery10.1016/S1359-6446(04)03276-3 ↗
6. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats10.1016/j.biomaterials.2006.07.046 ↗
7. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload10.1016/j.biomaterials.2005.06.007 ↗
8. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy10.1021/bc0499127 ↗
9. PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression10.1208/s12248-009-9116-1 ↗
10. PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation10.1007/s11095-009-9992-1 ↗
11. Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells10.1248/cpb.59.63 ↗
12. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin10.1016/j.biomaterials.2009.07.051 ↗
13. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors10.1016/j.biomaterials.2009.04.012 ↗
14. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel10.1016/j.biomaterials.2011.11.022 ↗
15. Reduction-degradable PEG-b–PAA-b–PEG triblock copolymer micelles incorporated with MTX for cancer chemotherapy10.1016/j.colsurfb.2013.07.056 ↗
16. Rapidly disassembling nanomicelles with disulfide-linked PEG shells for glutathione-mediated intracellular drug delivery10.1039/c0cc04983b ↗
17. PAMAM dendrimers undergo pH responsive conformational changes without swelling10.1021/ja8100227 ↗
18. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors10.1021/mp100185f ↗
19. Redox and pH-responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates with disulfide linkages for efficient intracellular drug release10.1016/j.colsurfb.2014.09.024 ↗
20. Poly(amidoamine) dendrimer–drug conjugates with disulfide linkages for intracellular drug delivery10.1016/j.biomaterials.2008.12.054 ↗
21. A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating10.1016/j.colsurfb.2006.02.006 ↗
22. PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation10.1007/s11095-009-9992-1 ↗
23. Targeted delivery of doxorubicin into cancer cells using a folic acid–dendrimer conjugate10.1039/c1py00179e ↗
24. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release10.1016/j.jconrel.2013.01.001 ↗
25. PH and redox dual responsive nanoparticle for nuclear targeted drug delivery10.1021/mp300274g ↗
26. Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro and in vivo live cell imaging10.1016/j.jconrel.2013.08.034 ↗
27. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors10.1158/1078-0432.CCR-05-0343 ↗
28. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin10.1021/bc200062q ↗
29. Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(γ-glutamic acid) complexes as a gene delivery vector10.1016/j.biomaterials.2010.08.081 ↗
30. Uptake mechanisms of non-viral gene delivery10.1016/j.jconrel.2011.09.093 ↗
31. GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation10.2147/IJN.S53310 ↗
32. Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature10.1016/j.nano.2011.05.003 ↗
33. Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style10.1016/j.biomaterials.2009.10.044 ↗
34. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes10.1021/mp100171c ↗
35. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) commodified liposomal delivery system via systemic administration10.1021/mp200100f ↗
36. Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo
37. A critical evaluation of the mechanism of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
38. Nanocarriers’ entry into the cell: relevance to drug delivery10.1007/s00018-009-0053-z ↗
39. The effect of surface functionality on cellular trafficking of dendrimers10.1016/j.biomaterials.2008.04.038 ↗
40. The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type10.1016/j.ymthe.2006.07.006 ↗
41. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages10.1083/jcb.135.5.1249 ↗
42. Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases10.1002/1097-0142(20011101)92:9<2297::AID-CNCR1576>3.0.CO;2-B ↗
43. The role of glutathione in the regulation of apoptosis10.1046/j.1365-2362.1999.00447.x ↗
44. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin10.1016/j.biomaterials.2014.08.008 ↗